
Başlık:
Solid state development and processing of pharmaceutical molecules : salts, cocrystals, and polymorphism
Yazar:
Gruss, Michael, author.
ISBN:
9783527823055
9783527823048
Fiziksel Tanımlama:
1 online resource
Seri:
Methods and principles in medicinal chemistry ; volume 79
Methods and principles in medicinal chemistry ; v. 79.
İçerik:
Cover -- Title Page -- Copyright -- Contents -- Series Editors Preface -- Preface -- Chapter 1 Aspects for Developing and Processing Solid Forms -- 1.1 Aspects for Developing and Processing Solid Forms -- 1.1.1 Introduction -- 1.1.2 Education and Personal Background -- 1.1.3 Societal Impact - Fishing in Foreign Waters -- 1.1.3.1 Motivation -- 1.1.3.2 The Personal Dimension -- 1.1.3.3 Beyond the Impact on Individuals -- 1.1.3.4 Understanding the Market - Not an Easy Task -- 1.1.3.5 Benefits of an Interdisciplinary Mindset -- 1.1.4 The Basis for Mutual Understanding -- 1.1.5 Crystallization is a Separation, Not a Separated Process -- 1.1.6 Some Early Information About Solid-state Properties -- 1.1.7 Digitalization (Not Only) in the Laboratory -- 1.1.7.1 Prerequisites - Technology and People -- 1.1.7.2 Connect Data and the Right Information from Synthesis and Analysis -- 1.1.7.3 Contributions and Choices -- 1.1.7.4 Application of Digitalization -- 1.1.7.5 Fully Digitalized Infrastructure -- 1.1.8 Basic Terms and Concepts in the World of Solid State -- 1.1.8.1 Crystalline and Amorphous -- 1.1.8.2 Crystallization and Precipitation -- 1.1.8.3 Understanding the Phase Diagram - Analytical Characterization of the Solid-Liquid and Solid-Solid Systems -- 1.1.8.4 Polymorphism -- 1.1.8.5 Multi-component Compounds - Salt, Cocrystal, Solvate, and Hydrate -- 1.1.8.6 Solvates, Hydrates, Non-solvated Forms, or Ansolvates -- 1.1.8.7 Dispersed Primary Particles, Aggregates, and Agglomerates -- 1.1.8.8 Particle Size and Particle Size Distribution (PSD) -- 1.1.9 Investigating and Understanding the Polymorphic Landscape -- 1.1.10 Performing the Crystallization -- 1.1.11 Objectives for the Optimization of Crystallization Processes and Solid-State Properties -- 1.1.12 Implementation of In Silico and Simulation Techniques.
1.1.13 Saving the Investment - Addressing Intellectual Property Rights -- 1.1.14 Concluding Remarks -- List of Abbreviations -- References -- Chapter 2 Determination of Current Knowledge -- 2.1 Why Is it Important to Search for Relevant Information Before Starting a Solid-State Project? -- 2.2 Where to Begin a Literature Search for a Solid-State Project? -- 2.2.1 Literature Search -- 2.2.1.1 Focusing Your Literature Search -- 2.2.2 Staying on Top of the Latest Publications -- 2.3 Patent Search -- 2.3.1 Types of Patent Reports -- 2.3.2 Understanding the Elements of Patents -- 2.3.3 Patent Classification -- 2.3.4 Patent Databases -- 2.3.4.1 Free Patent Databases -- 2.4 Other Useful Resources for Solid-State Projects -- 2.4.1 Cambridge Structural Database -- 2.4.2 Crystallography Open Database -- List of Abbreviations -- References -- Chapter 3 Systematic Screening and Investigation of Solid-State Landscapes -- 3.1 Introduction -- 3.2 General Aspects of Solid-State Investigations in Early Drug Discovery Phase -- 3.3 Transition Phase from Late Stage Research to Early Stage Development -- 3.4 Solid-State Characteristics in Preclinical Formulations -- 3.5 API-crystallization Strategy in Candidate Profiling Phase -- 3.6 Selection Criteria of a Suitable Solid Form -- 3.7 Knowledge Management -- 3.8 Control of Solid Form Properties in Development -- 3.9 Exploratory Crystallization Experiments -- List of Abbreviations -- References -- Chapter 4.1 Solid-State Characterization Techniques: Microscopy -- 4.1.1 Microscopy -- 4.1.1.1 Optical Microscopy -- 4.1.1.1.1 Bright-Field Microscopy -- 4.1.1.1.2 Dark-Field Microscopy -- 4.1.1.1.3 Polarized Light Microscopy -- 4.1.1.1.4 Other Optical Microscopy Variants -- 4.1.1.2 Electron Microscopy -- 4.1.1.2.1 Scanning Electron Microscopy -- 4.1.1.2.2 Transmission Electron Microscopy -- 4.1.1.3 Atomic Force Microscopy.
4.1.1.4 Microscopy in Regulatory Documents -- List of Abbreviations -- References -- Chapter 4.2 Standards and Trends in Analytical Characterization - X-ray Diffraction (XRD) -- 4.2.1 X-ray Diffraction -- 4.2.1.1 Introduction -- 4.2.1.2 Measurement Principles -- 4.2.1.2.1 The Crystal Lattice -- 4.2.1.2.2 The Space Group Symmetry -- 4.2.1.2.3 What Determines a Diffraction Peak -- 4.2.1.2.4 X-ray Scattering Technics -- 4.2.2 Technics -- 4.2.2.1 Single Crystal X-ray Diffraction -- 4.2.2.2 Powder X-ray Diffraction -- 4.2.2.2.1 Alternative Methods for Structure Determination -- 4.2.3 Instrumentation -- 4.2.3.1 X-ray Sources -- 4.2.3.2 Diffractometer Geometries -- 4.2.3.2.1 Reflection Geometry -- 4.2.3.2.2 Transmission Geometry -- 4.2.3.2.3 Benchtop Diffractometers -- 4.2.3.3 Detectors -- 4.2.3.4 Peak Asymmetry -- 4.2.3.5 Reproducibility of Diffraction Patterns: The Texture Effect (Preferred Orientation) -- 4.2.3.6 Databases of Known Diffraction Patterns -- 4.2.4 Measurement -- 4.2.4.1 Instrument Calibration -- 4.2.4.2 Sample Preparation -- 4.2.5 Data Evaluation -- 4.2.5.1 Qualitative Phase Analysis -- 4.2.5.1.1 Phase Identification or Identity Check -- 4.2.5.1.2 Amorphous Content -- 4.2.5.2 Quantification -- 4.2.5.2.1 Based on Calibration Curve -- 4.2.5.2.2 Based on Internal Standard Addition -- 4.2.5.2.3 Based on Rietveld Refinement -- 4.2.5.3 Advanced Phase Analysis -- List of Abbreviations -- References -- Further Reading -- Chapter 4.3 Standards and Trends in Solid-State Characterization Techniques - Thermal Analysis -- 4.3.1 Introduction -- 4.3.2 Thermal Analysis in Drug Development -- 4.3.2.1 Solid form Landscape -- 4.3.2.2 Compatibility Studies -- 4.3.2.3 Other Applications -- 4.3.3 Methods -- 4.3.3.1 Differential Scanning Calorimetry -- 4.3.3.1.1 Techniques -- 4.3.3.1.2 Sample Preparation and Measuring Parameters -- 4.3.3.1.3 Evaluation.
4.3.3.1.4 Special Applications -- 4.3.3.1.5 Detection Limits -- 4.3.3.2 Thermogravimetric Analysis -- 4.3.3.2.1 Technique -- 4.3.3.2.2 Sample Preparation and Measuring Parameters -- 4.3.3.2.3 Evaluation -- 4.3.3.2.4 Special Applications -- 4.3.4 Case Studies -- 4.3.4.1 Understanding Polymorphic Transitions -- 4.3.4.2 The Power of Ultra-fast Heating Rates -- 4.3.4.3 Understanding Amorphous Phases -- 4.3.4.4 Identification of Solvate Structures -- 4.3.5 Quality and Regulatory Aspects -- 4.3.6 Outlook -- Acknowledgments -- List of Abbreviations -- Notes -- References -- Chapter 4.4 Standards and Trends in Solid-State Characterization Techniques: Infrared (IR) Spectroscopy -- 4.4.1 Infrared (IR) Spectroscopy -- 4.4.1.1 Introduction -- 4.4.1.2 IR Spectroscopy as Identity Method for Drug Substances -- 4.4.1.2.1 Transmission Mode -- 4.4.1.2.2 Attenuated Total Reflectance (ATR) -- 4.4.1.2.3 Sample preparation -- 4.4.1.2.4 Analysis and Reporting -- 4.4.1.2.5 Examples and Limitations -- 4.4.1.2.6 Method Validation of IR Spectroscopy Identification and Quantification Methods -- 4.4.1.3 Application of IR Microscopy-Imaging Methods in Drug Development -- 4.4.1.3.1 Spatial Resolution -- 4.4.1.3.2 Measurement Setups -- 4.4.1.3.3 Case Studies -- 4.4.1.4 Conclusion -- List of Abbreviations -- References -- Chapter 4.5 Transmission Raman Spectroscopy - Implementation in Pharmaceutical Quality Control -- 4.5.1 Raman Spectroscopy - From Research to Broad Applications in Industry -- 4.5.1.1 Objective -- 4.5.1.1.1 History -- 4.5.1.1.2 Introduction -- 4.5.1.1.3 The Raman Effect -- 4.5.2 Analytical use of Raman Spectroscopy for Pharmaceutical Purposes -- 4.5.2.1 Transmission Raman Spectroscopy (TRS) -- 4.5.2.1.1 Principles of Transmission Raman Spectroscopy -- 4.5.2.1.2 A Practical Guide to a Successful Business Case.
Özet:
Solid State Development and Processing of Pharmaceutical Molecules covers the entire pharmaceutical value chain. The authors - noted experts on the topic - examine the importance of the solid state form of chemical and biological drugs and review the development, production, quality control, formulation, and stability of medicines. The book explores the most recent trends in the digitization and automation of the pharmaceutical production processes that reflect the need for consistent high quality. It also includes information on relevant regulatory and intellectual property considerations. This resource is aimed at professionals in the pharmaceutical industry and offers an in-depth examination of the commercially relevant issues facing developers, producers and distributors of drug substances.
Notlar:
John Wiley and Sons
Konu Terimleri:
Tür:
Yazar Ek Girişi:
Elektronik Erişim:
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527823048Kopya:
Rafta:*
Kütüphane | Materyal Türü | Demirbaş Numarası | Yer Numarası | Durumu/İade Tarihi | Materyal Ayırtma |
|---|---|---|---|---|---|
Arıyor... | E-Kitap | 597046-1001 | RS403 .G78 2022 | Arıyor... | Arıyor... |
